文献速递头颈外科小儿耳鼻咽喉

儿童T1期甲状腺乳头状癌的甲状腺腺叶切除术研究

Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

本研究回顾性分析102例儿童T1期甲状腺乳头状癌患者,评估双侧病变和淋巴结转移情况。结果显示T1a和T1b肿瘤中双侧病变分别占19.2%和20%,中央区淋巴结转移分别占28.8%和26%。无淋巴结转移证据的患者中95%为单侧病变,提示部分低危患儿可考虑腺叶切除而非全甲状腺切除。

要点

  • 儿童T1a期甲状腺乳头状癌中双侧病变占19.2%,中央区淋巴结转移占28.8%。
  • 无病理淋巴结转移证据的患者中,95%为单侧甲状腺乳头状癌。
  • 单侧多灶性与双侧病变及中央区淋巴结转移相关,淋巴结转移数目≥4个与双侧病变相关。

核心结论

  • 对于术前超声无临床明显淋巴结转移的单灶性T1a期儿童甲状腺乳头状癌,可考虑甲状腺腺叶切除加中央区淋巴结清扫。
  • 若术后病理无单侧多灶性或阳性淋巴结少于4个,可考虑密切观察。

研究设计与样本

  • 回顾性队列研究,纳入2009年1月1日至2020年5月31日期间在三级医疗中心接受手术治疗的102例T1期甲状腺乳头状癌患儿,其中T1a期52例、T1b期50例。

主要发现

  • T1a期患者中双侧病变10例(19.2%),中央区淋巴结转移15例(28.8%)。
  • T1b期患者中双侧病变10例(20%),中央区淋巴结转移13例(26%)。
  • T1a期患者中,单侧多灶性与双侧病变相关(OR 2.1,95%CI 1.3-3.4),与中央区淋巴结转移相关(OR 5.1,95%CI 1.5-17.6)。
  • T1a期患者中,中央区淋巴结转移与双侧病变相关(OR 20.0,95%CI 3.5-115.0),阳性淋巴结≥4个与双侧病变相关(OR 8.6,95%CI 1.2-60.9)。
  • T1b期患者中,单侧多灶性与双侧病变相关(OR 1.8,95%CI 1.3-2.7);相比T1a期,T1b期患者侧颈淋巴结转移风险增高(OR 3.7,95%CI 1.0-14.5)。

关键数值与推荐

  • 无病理淋巴结转移证据的患者中,单侧甲状腺乳头状癌占95%。

临床怎么用

  • 对于严格筛选的单灶性T1a期儿童甲状腺乳头状癌且术前超声无临床明显淋巴结转移者,可行腺叶切除加中央区淋巴结清扫。
  • 术后病理若确认无单侧多灶性且阳性淋巴结少于4个,可考虑密切观察而非补充全甲状腺切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The current recommendation for pediatric patients with papillary thyroid cancer (PTC) is a total thyroidectomy. This recommendation applies to all stages of PTC, including papillary thyroid microcarcinoma (≤1 cm, T1a) tumors. OBJECTIVE: To evaluate the characteristics of American Joint Committee on Cancer T1 PTC tumors in a large pediatric population and to identify a subgroup of patients who may benefit from a thyroid lobectomy instead of a total thyroidectomy. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted from January 1, 2009, to May 31, 2020. The study took place at a tertiary care medical center and included 102 patients who were surgically treated for T1 PTC: 52 with stage T1a (≤1 cm) tumors and 50 with stage T1b (>1 cm but ≤2 cm) tumors. MAIN OUTCOMES AND MEASURES: Primary outcomes included the presence of bilateral disease and lymph node metastasis. RESULTS: A total of 102 patients (mean age, 15.3 years [range, 9.7-18.9 years]; 84 girls [82.4%]) were included in the analysis. Among 52 patients with T1a tumors, 10 (19.2%) had bilateral disease, and 15 (28.8%) had central neck lymph node (N1a) metastasis. Among 50 patients with T1b tumors, 10 (20%) had bilateral and 13 (26%) had N1a disease. Of those with T1a, unilateral multifocality was associated with bilateral disease (odds ratio [OR], 2.1; 95% CI, 1.3-3.4) and N1a disease (OR, 5.1; 95% CI, 1.5-17.6). Both N1a disease (OR, 20.0; 95% CI, 3.5-115.0) and ≥4 positive lymph nodes (OR, 8.6; 95% CI, 1.2-60.9) were associated with bilateral disease. In patients with no pathologic evidence of lymph node metastasis (N0), there was a 95% rate of unilateral PTC. In patients with T1b tumors, unilateral multifocality was also associated with bilateral disease (OR, 1.8; 95% CI, 1.3-2.7). Patients with T1b tumors had an increased risk of lateral (N1b) neck lymph node metastasis when compared with those with T1a tumors (OR, 3.7; 95% CI, 1.0-14.5). CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that, in patients with unifocal T1a PTC without clinically evident nodal disease on preoperative ultrasonography, a thyroid lobectomy and central neck dissection may be considered. If there is no evidence of unilateral multifocality or if there are fewer than 4 positive lymph nodes on postoperative pathology, then close observation may be considered. These findings have substantial clinical implications and may result in practice changes regarding the extent of thyroid surgery on low-stage pediatric PTC.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Sudoko CK, Jenks CM, Bauer AJ, et al. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34554217. doi:10.1001/jamaoto.2021.2359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。